Aktywa Zmiana Data
ALKERMES USD 1.58B 57.83M 2026-09
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amarin USD 612.88M 10.12M 2026-09
ANI Pharmaceuticals USD 902.82M 77.39M 2026-09
Anika Therapeutics USD 99.19M 5.63M 2026-06
Arrowhead Research USD 1.67B 168.34M 2026-06
Eisai JPY 883.01B 121.38B 2026-06
Emergent BioSolutions USD 679.5M 41.3M 2023-12
GlaxoSmithKline GBP 17.9B 336M 2026-09
Heron Therapeutics USD 229.84M 861K 2026-06
Insmed USD 1.71B 72.59M 2026-09
Ligand Pharmaceuticals USD 608.23M 848.88M 2026-09
Merck USD 38.94B 2.26B 2026-09
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Neurocrine Biosciences USD 2.01B 370.7M 2026-09
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 10.3B 9.68B 2026-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Ultragenyx Pharmaceutical USD 544M 62M 2026-09
Veracyte USD 467.88M 106.9M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09